on Aug 29,2023
Quebec City, Canada, August 28, 2023 — Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, today announced the appointment of …
Read Storyon Jun 13,2023
Québec City, Canada, June 13, 2023 – Feldan Therapeutics, a biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, has announced the initial closing …
Read Storyon Apr 18,2023
MONTREAL, April 18, 2023 – CQDM is proud to announce the funding of a project worth $503,779 aiming at optimizing a new drug delivery platform in the lungs to treat …
Read Storyon Mar 20,2023
Feldan Therapeutics is pleased to share the promising results of FLD103 to treat basal cell carcinoma. A poster presented at the WCH23 Dermatology Conference last January (Intralesional Treatment of Basal …
Read Storyon Jan 18,2022
Quebec City, Canada, January 18, 2022 - Feldan Therapeutics, a biopharmaceutical company that develops therapeutics based on its proprietary intracellular delivery platform, announced today it was awarded funding by the …
Read Storyon Apr 14,2021
Read more on pages 54 to 57: BIOTECanada Insights sping 2021 …
Read Storyon Apr 7,2021
Congratulations to the team at NIH Common Fund’s Somatic Cell Genome Editing (SCGE) program for publishing their work in the journal Nature. Feldan is honoured to be part of this …
Read Storyon Feb 9,2021
Québec, Canada, February 9, 2021 – Feldan Therapeutics, a biotechnology company that develops therapeutics based on the intracellular delivery of proteins and peptides, announces the appointment of Dr. David J …
Read Storyon Jan 14,2021
Quebec City, Canada, January 14, 2021 – Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on the intracellular delivery of proteins and peptides, announces the creation …
Read Storyon Jun 16,2020
Quebec City, Canada, June 16, 2020, Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on its intracellular delivery technology, today announced the appointment of Dr. Robert …
Read Story
2666, Boul. du Parc Technologique, Suite 290
Quebec, Qc, Canada,
G1P 4S6
Phone: 1-418-872-7277
Email: info@feldan.com